Call for applications for support of early-stage health technology and technology biotechnology companies at the intersection of health technology and pharmaceutical research and development.

Listed on GrantGunner. Last checked 16 Nov 2026.

About this grant

A specialized accelerator program designed for high-potential companies operating at the intersection of health technology, digital biotech, and pharmaceutical research and development. The three-month hybrid program helps early-stage founders refine value propositions and build partnerships in the global pharmaceutical industry, offering mentorship and access to the Basel life sciences network.

Browse all open grants

More grants from EU Funding Portal